Literature DB >> 9657811

Levonorgestrel intrauterine device can be left in place for five years.

M Harrison-Woolrych, J M Raine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9657811      PMCID： PMC1113513          DOI： 10.1136/bmj.317.7151.149a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Data support extended use of levonorgestrel intrauterine systems.

Authors:  D Mansour; J Guillebaud
Journal:  BMJ       Date:  1998-05-30

2.  Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.

Authors:  I Sivin; S el Mahgoub; T McCarthy; D R Mishell; D Shoupe; F Alvarez; V Brache; E Jimenez; J Diaz; A Faundes
Journal:  Contraception       Date:  1990-10       Impact factor: 3.375

3.  Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.

Authors:  I Sivin; J Stern; E Coutinho; C E Mattos; S el Mahgoub; S Diaz; M Pavez; F Alvarez; V Brache; F Thevenin
Journal:  Contraception       Date:  1991-11       Impact factor: 3.375
  3 in total
  2 in total

Review 1.  Medical treatment of uterine leiomyoma.

Authors:  Mohamed Sabry; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2012-02-28       Impact factor: 3.060

Review 2.  Recent advances in managing and understanding menstrual disorders.

Authors:  Luis Bahamondes; Moazzam Ali
Journal:  F1000Prime Rep       Date:  2015-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.